LILIUMX
LIVE

Serial Number

79397609

Owner

Valink Therapeutics Inc.

Attorney

Matthew A. Homyk

Filing Date

Mar 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LILIUMX Trademark

Serial Number: 79397609 • Registration: 7895169

LILIUMX is a trademark filed by Valink Therapeutics Inc. on March 5, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Valink Therapeutics Inc. (5 trademarks)

2261 Market Street #4161

Entity Type: 03

Trademark Details

Filing Date

March 5, 2024

Registration Date

August 19, 2025

Published for Opposition

July 1, 2025

Goods & Services

Scientific and technological services and research and design relating thereto in the field of medicine; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemistry drug discovery services; scientific laboratory services; medical research laboratory services; consultancy in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 19, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 2, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 2, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 30, 2025 OPNX
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 19, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 12, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 4, 2025 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 30, 2025 XAEC
ASSIGNED TO LIE
May 30, 2025 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 29, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 29, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 29, 2025 CNEA
NEW REPRESENTATIVE AT IB RECEIVED
May 16, 2025 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 22, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 22, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 15, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 12, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 20, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 13, 2024 REPR